Lee Financial’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-18
Closed -$1.25K – 877
2023
Q3
$1.25K Hold
18
– – ﹤0.01% 758
2023
Q2
$1.7K Buy
+18
New +$1.56K ﹤0.01% 684
2022
Q4
– Sell
-7
Closed -$1K – 949
2022
Q3
$1K Sell
7
-271
-97% -$26.1K ﹤0.01% 754
2022
Q2
$26K Sell
278
-13
-4% -$1.35K ﹤0.01% 303
2022
Q1
$34K Buy
291
+22
+8% +$2.47K 0.01% 275
2021
Q4
$35K Buy
269
+5
+2% +$583 0.01% 292
2021
Q3
$30K Hold
264
– – 0.01% 277
2021
Q2
$27K Hold
264
– – 0.01% 284
2021
Q1
$22K Hold
264
– – 0.01% 295
2020
Q4
$24K Hold
264
– – 0.01% 266
2020
Q3
$21K Hold
264
– – 0.01% 303
2020
Q2
$18K Hold
264
– – 0.01% 287
2020
Q1
$17K Hold
264
– – 0.01% 240
2019
Q4
$21K Hold
264
– – ﹤0.01% 251
2019
Q3
$19K Hold
264
– – ﹤0.01% 255
2019
Q2
$16K Hold
264
– – ﹤0.01% 285
2019
Q1
$17K Hold
264
– – ﹤0.01% 267
2018
Q4
$13K Hold
264
– – ﹤0.01% 253
2018
Q3
$15K Hold
264
– – ﹤0.01% 277
2018
Q2
$13K Hold
264
– – ﹤0.01% 429
2018
Q1
$12K Hold
264
– – ﹤0.01% 437
2017
Q4
$10K Hold
264
– – ﹤0.01% 322
2017
Q3
$10K Hold
264
– – ﹤0.01% 329
2017
Q2
$10K Hold
264
– – ﹤0.01% 316
2017
Q1
$8K Hold
264
– – ﹤0.01% 306
2016
Q4
$8K Buy
+264
New +$8.55K ﹤0.01% 320

Other funds holding EW

Lee Financial's EW Position: Q4 2023 in Review

Lee Financial sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 18 shares — an estimated $1.25K sold.

Lee Financial first reported a position in EW in Q4 2016 and held it in 26 quarters. The position peaked at $35K in Q4 2021. 1,245 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • Lee Financial reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
  • Lee Financial sold 18 Edwards Lifesciences shares in Q4 2023, an estimated $1.25K.
  • Lee Financial first reported a position in Edwards Lifesciences in Q4 2016 and held it in 26 quarters.
  • Lee Financial's Edwards Lifesciences position peaked at $35K in Q4 2021.
  • 1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Lee Financial's 13F filing for Q4 2023, filed 8 Feb 2024.